2nd Quarter - Amendment
INTEGRATED SOLUTIONS GROUP for TEVA PHARMACEUTICALS USA
Client
Income
$50,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 19, 2011 | $50,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Oct 20, 2011 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S.23 America Invents Act H.R. 1249 America Invents Act Monitored legislation concerning promotion of generic drug use and medicaid
| Lobbyist | Covered position, as disclosed |
|---|---|
| MOSES BOYD | Counsel, Senate Commerce Committee |
| MYCHAL S BOYD | — |
| G JOHN O'HANLON | — |
| ADAM S OLSEN | — |
Medicare/Medicaid MMM
Monitored legislation affecting medicaid and settlements
| Lobbyist | Covered position, as disclosed |
|---|---|
| MOSES BOYD | Counsel, Senate Commerce Committee |
| MYCHAL S BOYD | — |
| G JOHN O'HANLON | — |
| ADAM S OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.